SCHEMBL17320489

SCHEMBL17320489

CCc1ccc(N2CCN(C(=O)CO)CC2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 1/20 0.61
MAPT P10636 5/20 0.57
ALDH1A1 P00352 4/20 0.57
KMT2A Q03164 3/20 0.57
HTT P42858 3/20 0.57
MEN1 O00255 2/20 0.57
GAA P10253 2/20 0.57
GFER P55789 2/20 0.57
KDM4E B2RXH2 1/20 0.57
HSP90AA1 P07900 1/20 0.57
HSP90AB1 P08238 1/20 0.57
ALOX15 P16050 1/20 0.57
TSHR P16473 1/20 0.57
ALOX12 P18054 1/20 0.57
MAPK1 P28482 1/20 0.57
HSD17B10 Q99714 1/20 0.57
TDP1 Q9NUW8 1/20 0.57
POLB P06746 1/20 0.55
LMNA P02545 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20883675 0.94 AKR1C3 (0.56) AKR1C3MAPTALDH1A1KMT2AHTT
SCHEMBL12826300 0.88 MAPT (0.54) MAPTALDH1A1KMT2AHTTMEN1
SCHEMBL25844190 0.86 MAPT (0.65) MAPTALDH1A1KMT2AHTTMEN1
SCHEMBL25844191 0.84 LMNA (0.57) MAPTALDH1A1KMT2AHTTMEN1
SCHEMBL764335 0.83 MAPT (0.76) MAPTALDH1A1KMT2AHTTMEN1
SCHEMBL14924441 0.83 AKR1C3 (0.65) AKR1C3MAPTALDH1A1KMT2AHTT
SCHEMBL11919049 0.83 MAPT (0.53) MAPTALDH1A1KMT2AHTTMEN1
SCHEMBL17320597 0.82 RORC (0.54) MAPTALDH1A1KMT2AHTTMEN1
SCHEMBL24451826 0.81 AKR1C3 (0.62) AKR1C3MAPTALDH1A1KMT2AHTT
SCHEMBL28758087 0.80 KDM4E (0.61) MAPTALDH1A1KMT2AHTTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015187684-A1 TANK-BINDING KINASE INHIBITOR COMPOUNDS GILEAD SCIENCES, INC. (US) 2015-12-10 WO disclosed